A device to close the left atrial appendage of a patient including a hollow shell having opposed male and female ratchet latches with the shell moveable into the left atrial appendage orifice to close the orifice by interconnecting the latches to expand the shell in conformance with the profile of the orifice.

Disclosed are a left atrial appendage occlusion device (100, 300) and a left atrial appendage occlusion system. A connecting member (140, 240, 340, 440) comprises a first unit (140a, 240a, 440a) and a second unit (140b, 240b, 440b), wherein the first unit (140a, 240a, 440a) is connected to a first frame (110, 310, 410), the second unit (140b, 240b, 440b) is connected to a second frame (120, 320, 420), and the first unit (140a, 240a, 440a) is rotatably connected to the second unit (140b, 240b, 440b). Alternatively, the connecting member (140, 240, 340, 440) comprises the first unit (140a, 240a, 440a), the second unit (140b, 240b, 440b) and a third unit (140c, 240c), wherein the first unit (140a, 240a, 440a) is connected to the first frame (110, 310, 410), the second unit (140b, 240b, 440b) is connected to the second frame (120, 320, 420), the first unit (140a, 240a, 440a) is rotatably connected to the third unit (140c, 240c), and the second unit (140b, 240b, 440b) is rotatably connected to the third unit (140c, 240c). Thereby, with regard to left atrial appendages having lumens of different shapes, the relative positions of the first frame (110, 310, 410) and the second frame (120, 320, 420) can be changed by means of the connecting member (140, 240, 340, 440), i.e., the shape of the left atrial appendage occlusion device (100, 300) is adjusted so as to be capable of being adapted to left atrial appendages having lumens of different shapes.

According to the present disclosure, there is provided a device which can have a funnel catheter having an expandable distal tip. The funnel catheter can originally be placed in a collapsed configuration for delivery through vasculature to a target thrombus location. Once positioned, the expandable tip can be radially expanded to create a funnel for aspirating or retrieving clots from a vessel. The funnel catheter can be at least partially enclosed by an outer sheath for purposes of delivery to the target site or to assist in expansion of the funnel catheter tip.

Embodiments of the present disclosure comprise occlusion and drug delivery devices and methods. One aspect of the disclosure comprises a drug delivery device comprising an inner expansion member and an outer drug delivery component. Another aspect of the disclosure comprises bioabsorbable, lumen-occluding implants.

A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.

A device (1, 30, 40, 50, 60) for denuding a vein comprises a vein denuding head (3) operatively attached to an elongated catheter member (2) and configured for transluminal delivery and deployment in the vein. The vein denuding head comprises a helical coil (4) that is self-adjustable from an uncoiled delivery configuration suitable for transluminal delivery within the catheter member and a coiled deployed configuration having a diameter greater than the vein to be denuded that circumferentially engages an internal lumen of the vein when deployed. The helical coil has an abrasive surface configured to circumferentially denude the internal lumen of the vein when the coil is moved axially along the body lumen in the coiled configuration. The helical coil may be a single helical coil element.

A tricuspid regurgitation treatment tool to be inserted into the pulmonary artery is proposed. The tricuspid regurgitation treatment tool to be inserted into the pulmonary artery is used to verify whether the right ventricular dysfunction may occur when treating the tricuspid regurgitation by surgeries or other permanent treatments. A test insertion of the tricuspid regurgitation treatment tool to be inserted into the pulmonary artery is made to pass obliquely through the tricuspid valve of a patient, and after a certain time has elapsed, the tool is removed. The tricuspid regurgitation treatment tool to be inserted into the pulmonary artery includes: a blocking part blocking the tricuspid valve; and an insertion tube provided with a guidewire-guiding lumen formed therein to be movable along the guidewire.

This invention relates to a hemostatic member using chitosan having superior hemostatic activity, and more particularly to a chitosan-based hemostatic member for the cervix, suitable for use through insertion into an affected part upon cervical biopsy or surgery, configured to include a hemostatic pack having a projection at an upper end thereof through tying with a thread so as to form a spherical shape using chitosan nonwoven fabrics having a hemostatic function, wherein the thread contains an X-ray-sensitive material, thereby realizing effective hemostasis of the affected part upon cervical biopsy or surgery.

Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.

Left atrial appendage (LAA) occlusion device including a membrane, a plurality of fixation splines, at least two electrical conductors and an interconnect, the interconnect positioned in the membrane for coupling the fixation splines and the electrical conductors, the fixation splines for affixing the LAA occlusion device to an ostium of the LAA and the electrical conductors for applying high voltage electricity to the ostium of the LAA, wherein the membrane physically occludes the LAA and the electrical conductors are used to electroporate the ostium of the LAA via the high voltage electricity, thereby electrically isolating the LAA.